 clinical pilot study surgery intraoperative pelvic hyperthermochemotherapy local recurrence rectal cancer Intraoperative pelvic hyperthermochemotherapy IOPHC mitomycin MMC patients resectable advanced rectal cancer attempt postoperative local recurrence rectal amputation extended lymphadenectomy IOPHC physiologic saline micrograms/mL MMC minutes apparatus IOPHC end IOPHC esophageal temperature cooling Antitumor efficacy complications IOPHC group findings rectal cancer patients surgery period time Operation time IOPHC treatment cytologic examinations pelvic lavage IOPHC treatment viable cancer cells patients postoperative exudate pelvic cavity patients control group local recurrence IOPHC group local recurrence months writing Postoperative complications groups IOPHC treatment favorable method cancer cells postoperative local recurrence rectal cancer